Post-COVID Fungal Osteomyelitis-Another Killer

Surender Pal Singh Sodhi1, Gursimrat Kaur Brar1, Deepinder Pal Singh Sodhi2

  • 1Department of Oral and Maxillofacial Surgery, Dasmesh Institute of Research and Dental Sciences, Faridkot, Punjab, India.

Insights

Fungal co-infections during COVID-19 pandemics may be overlooked. This study highlights cases of fungal infections in the maxilla and orbit following coronavirus disease 2019 (COVID-19) treatment.

Area of Science:

  • Infectious Diseases
  • Mycology
  • Ophthalmology
  • Otorhinolaryngology

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, has led to widespread global health challenges.
  • Previous outbreaks, such as SARS, indicated a potential for fungal co-infections.
  • There is a concern that fungal co-infections in COVID-19 patients may be underdiagnosed or misdiagnosed.

Purpose of the Study:

  • To investigate the potential for missed or misdiagnosed fungal co-infections in COVID-19 patients.
  • To report a case series of patients with fungal infections of the maxilla and orbit following COVID-19.
  • To present successful treatment outcomes and follow-up for these cases.

Main Methods:

  • Retrospective analysis of global SARS data.
  • Case series reporting of fungal infections in the maxilla and orbit.
  • Documentation of successful treatment and regular follow-up.

Main Results:

  • A retrospective analysis suggests fungal co-infections associated with COVID-19 might be missed or misdiagnosed.
  • The study presents cases of fungal infections affecting the maxilla and orbit in patients treated for COVID-19.
  • These patients were successfully treated and are under regular follow-up.

Conclusions:

  • Fungal co-infections are a potential complication of COVID-19 that warrants attention.
  • Early identification and management of fungal infections in the maxilla and orbit are crucial for COVID-19 patients.
  • Successful treatment outcomes are achievable with appropriate medical care and monitoring.

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
13
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
323
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
258
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
12
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
41
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
8.1K